A new vaccine manufacturing base will be built in Oxfordshire to produce new flu, Covid and respiratory virus jabs.
Covid-19 vaccine manufacturer Moderna will build its Innovation and Technology Centre in Harwell ‘to provide the UK public with access to mRNA vaccines for a wide range of respiratory diseases’.
The £150million facilities will create 100 million vaccines a year and the UK government has committed to buying a portion of the jabs for the NHS.
The move is set to create hundreds of jobs both in the construction as well as the operation of the manufacturing facility, which is expected to be operating in 2025.
It comes as rival jab giant AstraZeneca said last month that it was moving some operations to Ireland for tax purposes.